Do you want to read an article? Please log in or register.
Clinical Utility of Next Generation Sequencing in Concurrent EBUS-TBNA and Liquid Biopsies in NSCLC
Lung Cancer
RECOMMENDED
Related content
Tuberculosis
Clinical Utility of Metagenomic Next-Generation Sequencing in Adult Patients with Fever of Unknown Origin: A Retrospective Real-World Study
J Clin Med
Guo F, Zhang L, Liu Z, Zhou B, Fan H, Zhang D, Yang Q, Li T, Ge Y
doi: 10.3390/jcm15156038
RECOMMENDED
Interstitial Lung Disease
Clinical utility of lung biopsy in fibrotic interstitial lung disease
★ 3
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Am J Respir Crit Care Med
Mor E, Piciucchi S, Ravaglia C, Aronson K, Poletti V, Hariri LP, Khor YH, Churg A, Collins B, Fabre A, Adegunsoye A, Chung J, Cooper WA, Cottin V, Dotan Y, Hague C, Inoue Y, Jacob J, Martinez F, Podolanczuk AJ, Tomassetti S, Wells AU, Wijsenbeek MS, Yasufuku K, Dominy L, Mcdonald J, Sangari S, Ryerson CJ
doi: 10.1093/ajrccm/aamaf123
RECOMMENDED
Further Publications
EBUS-TBNA for lung cancer in the apical segment of the right upper lobe using a new EBUS scope
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
Respir Med Case Rep
Watanabe H, Oki M, Shinohara Y, Toshihiro O, Imaeda Y, Iwakoshi A
doi: 10.1016/j.rmcr.2026.102368
Lung Cancer
Clinical utility of comprehensive genomic profiling versus Oncomine Dx target test in pathological stage II-III non-small cell lung cancer
Sci Rep
Yano K, Kaseda K, Nakamura K, Okubo Y, Masai K, Hishida T, Nukaga S, Ohgino K, Terai H, Yasuda H, Kurebayashi Y, Fukunaga K, Nishihara H, Asakura K
doi: 10.1038/s41598-025-21559-5
Lung Cancer
Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1)
Lung Cancer
Itchins M, Alexander M, Kao S, Nagrial A, Brown LJ, Bowyer S, Parakh S, Moore M, Kong BY, Yeo N, Hughes BGM, Arulananda S, Chin V, Warburton L, Khoo T, Mersiades AJ, Leigh L, Rogers J, Pavlakis N, Solomon BJ
doi: 10.1016/j.lungcan.2026.109500
RECOMMENDED
Lung Cancer
Real-World Clinical Outcomes and Treatment Patterns in Advanced/Metastatic EGFR-Mutant NSCLC After Progression on First-Line Osimertinib for French Patients
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
Adv Ther
Girard N, Macouillard P, Byng D, Meng J, Coerts F, Hunter S, Struebing A, Xiong Y, Park S, Haq MI, Tymejczyk O, Chouaid C, Audigier-Valette C, Debieuvre D, Quantin X, Bosquet L, Pérol M
doi: 10.1007/s12325-025-03465-4
Lung Cancer
Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco
Clin Cancer Res
Gariazzo E, Elkrief A, Concannon K, Ognissanti D, Dodi A, Favorito V, Di Federico A, De Giglio A, Brunetti L, Santo V, Pecci F, Aldea M, Garbo E, Alessi JV, LoPiccolo J, Paoloni F, Nishino M, Sholl LM, Florez N, Rotow J, Frumm SM, Hong L, Zhang J, Gibbons D, Wang X, Landi L, Cipriani L, Rakaee M, Cortellini A, Tiseo M, Cappuzzo F, Ardizzoni A, Awad MM, Heymach JV, Scalera S, Maugeri-Saccà M, Metro G, Vokes N, Schoenfeld A, Ricciuti B
doi: 10.1158/1078-0432.CCR-25-4793
Lung Cancer
Clinical impact of local consolidative therapy in EGFR-mutant metastatic NSCLC: A propensity-matched multicenter analysis
Lung Cancer
Lee EH, Kim MH, Kang DH, Moon J, Kwak SH, Eom JS, Lee JE, Kim CY, Chang YS, Lee SH, Kim EY, Lee CY, Cho J
doi: 10.1016/j.lungcan.2026.109423
Asthma
Adherence to Biologic Therapies is Associated with Improved Clinical Outcomes and Reduced Healthcare Resource Utilization in Patients with Severe Asthma in Japan
J Asthma Allergy
Nagase H, Karsanji U, Kunishige H, Suzuki T, Vichiendilokkul A, Yuanita L, Sasakura N, Wang J, Noibi S
doi: 10.2147/JAA.S590261